Pharming Group N.V. ADS, each representing 10 ordinary shares (PHAR) Dividend History

Company News

• Pharming Group to participate in March investor conference

  Pharming Group N.V., a global biopharmaceutical company, announces that its management team will participate in the 37th Annual Roth Conference in March 2025, where they will hold a fireside chat and be available for one-on-one meetings.

  GlobeNewswire Inc.
• Pharming Group to participate in February investor conference

  Pharming Group N.V., a global biopharmaceutical company, announces that its management team will present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference on February 12, 2025.

  GlobeNewswire Inc.
• Pharming announces public cash offer to the shareholders of Abliva AB

  Pharming Group N.V. announced a recommended public cash offer to acquire all outstanding shares of Abliva AB, a biotechnology company focused on developing treatments for mitochondrial diseases. Abliva's lead product, KL1333, is currently in a pivotal clinical trial and has shown positive results in a proof-of-concept study.

  GlobeNewswire Inc.
• Pharming Group to participate in November investor conference

  Pharming Group N.V., a global biopharmaceutical company, announces that its CEO will present at the Jefferies London Healthcare Conference 2024 on November 20, 2024.

  GlobeNewswire Inc.
• Pharming Group (PHAR) Surges 7.2%: Is This an Indication of Further Gains?

  Pharming Group (PHAR) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

  Zacks Investment Research

  Featured Companies: URGN